This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Innovations in Insulin: New Opportunities to Individualize Therapy

Innovations in Insulin: New Opportunities to Individualize Therapy

Format

Webcast

Time to Complete

1.50 hours

Released

August 31, 2017

Expires

August 30, 2018
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM
1.50 / ANCC Contact Hours
1.50 / AANP Contact Hours (1.50 pharmacology credits)

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by an independent educational grant from Novo Nordisk Inc.

This activity is supported by an educational grant from Lilly.

Program Description

Vivian A. Fonseca, MD, and Jonathan D. Leffert, MD, combine their expertise and discuss emerging concepts, treatment advancements, and critical issues associated with the management of patients with type 2 diabetes mellitus. The discussion focuses on real-world patient management and includes case studies to facilitate integration of new knowledge into clinical practice.

Intended Audience

This activity was developed for primary care physicians, endocrinologists, physician assistants, nurse practitioners, nurses, and other healthcare providers.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Describe the contribution of fasting plasma glucose and postprandial glucose in cardiovascular risk
  • Identify patients for whom insulin is appropriate based on current guidelines for the treatment of type 2 diabetes mellitus
  • Initiate and titrate basal insulin to achieve glycemic control
  • Identify patients who are appropriate candidates for prandial insulin
  • Initiate and titrate prandial insulin to achieve glycemic control
  • Initiate a concentrated insulin formulation in appropriate patients
  • Individualize basal and prandial insulin therapy

Conflict Of Interest Disclosure Policy

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

Vivian A. Fonseca, MD
Professor of Medicine and Pharmacology
Tullis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, LA

Dr. Fonseca discloses the following:
Research Support: Asahi, Bayer
Consultant: Astra-Zeneca, Eli Lilly, Janssen, Novo Nordisk, Sanofi-Aventis, Takeda

Jonathan D. Leffert, MD
Managing Partner, North Texas Endocrine Center
President, American Association of Clinical Endocrinologists
Dallas, TX

Dr. Leffert discloses the following
Research Support: AbbVie, Astra-Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, KOWA Research Institute, Mylan GmbH, Novo Nordisk, Sanofi US

Planners and Managers Disclosures

Annenberg Center for Health Sciences
Charles Willis
, Director of Continuing Education, consults for Pfizer, Inc.
John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.
All other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Additional Content Planners
Gregory Scott, PharmD, RPh
(medical writer), has no significant relationships to disclose.
Mayer Davidson, MD (peer reviewer), has no significant relationships to disclose.
Heather Marie Gibson, BSN, MSN (lead nurse planner), has no significant relationships to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

A maximum of 1.50 contact hours may be earned for successful completion of this activity. Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.50 contact hours.

Credit

1.50

Type

CE for Nurse Practitioners

Accreditation Statement

Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

Designation Statement

This program is accredited for 1.50 contact hours which includes 1.50 hours of pharmacology. Program ID #5539.

Disclosure of Unlabeled Use

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue